Drug Approval | June 05, 2025
UK MHRA approves aumolertinib to treat non-small cell lung cancer
Aumolertinib can be used in patients who have tested positive for a mutation in a gene called epidermal growth factor receptor
Aumolertinib can be used in patients who have tested positive for a mutation in a gene called epidermal growth factor receptor
Usnoflast has previously also received ‘Orphan Drug Designation (ODD)’ from the USFDA
The Protect VL project was born out of a vision to reduce the environmental footprint of medical devices
Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
Sun Pharma has been involved in a patent infringement case with Incyte Corporation over LEQSELVI
Bloom has pioneered a technology to transform plant waste into valuable chemical products
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
FlexiTubes will showcase range of eco-friendly and innovative tube options
Subscribe To Our Newsletter & Stay Updated
